| Literature DB >> 31337350 |
Ambrogio P Londero1, Emma Rossetti2, Carla Pittini3, Angelo Cagnacci2, Lorenza Driul2.
Abstract
BACKGROUND: The increased potential for negative pregnancy outcomes in both extremes of reproductive age is a well-debated argument. The aim of this study was to analyze the prevalence and the outcome of pregnancies conceived at extreme maternal ages.Entities:
Keywords: Fetal intraventicular hemorrhage; Fetal periventricular leucomalacia; Maternal age; Pregnancy-related hypertensive disorders
Year: 2019 PMID: 31337350 PMCID: PMC6651936 DOI: 10.1186/s12884-019-2400-x
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Fig. 1a Time trend of the age groups analyzed during the study period. b Time trend of Average age and relative standard deviation. c Time trend of Average age and relative standard deviation in nulliparous and pluriparous women
Characteristics of the study population categorised by age group
| < 17 years (71) | 18–28 years (5714) | 29–39 years (15591) | > 40 years (1552) |
| |
|---|---|---|---|---|---|
| Maternal age (years) | 16.52 (±0.63) | 24.86 (±2.70) | 33.59 (±2.89) | 41.34 (±1.60) | 1,2,3,4,5,6 |
| Nulliparous women | 98.55% (68/69) | 69.84% (3858/5524) | 52.31% (7897/15097) | 38.22% (571/1494) | 1,2,3,4,5,6 |
| Low schooling | 76.06% (54/71) | 34.06% (1946/5714) | 18.27% (2848/15591) | 20.30% (315/1552) | 1,2,3,4,5,6 |
| Conception mode | |||||
| Spontaneous | 98.59% (70/71) | 99.46% (5683/5714) | 98.40% (15342/15591) | 96.13% (1492/1552) | 4,5,6 |
| Ovulation induction/IUI | 1.41% (1/71) | 0.35% (20/5714) | 0.59% (92/15591) | 0.52% (8/1552) | 4 |
| IVF/ICSI | 0.00% (0/71) | 0.19% (11/5714) | 1.01% (157/15591) | 3.35% (52/1552) | 4,5,6 |
| Gestational age at delivery (weeks) | 38.80 (±2.56) | 38.69 (±2.64) | 38.61 (±2.50) | 38.17 (±2.68) | 3,4,5,6 |
| Delivery < 32 weeks | 2.82% (2/71) | 3.65% (208/5705) | 3.02% (470/15547) | 3.80% (59/1552) | 4 |
| Delivery < 34 weeks | 2.82% (2/71) | 4.93% (281/5705) | 4.55% (707/15547) | 5.86% (91/1552) | 6 |
| Delivery < 37 weeks | 8.45% (6/71) | 9.87% (563/5705) | 9.90% (1539/15547) | 13.92% (216/1552) | 5,6 |
| Macro-region of origin | |||||
| Europe/Italy | 80.00% (56/70) | 81.29% (4637/5704) | 92.03% (14339/15581) | 94.71% (1469/1551) | 2,3,4,5,6 |
| Sub-Saharian Africa | 12.86% (9/70) | 6.54% (373/5704) | 3.61% (562/15581) | 2.45% (38/1551) | 1,2,3,4,5,6 |
| Arabian countries | 1.43% (1/70) | 5.84% (333/5704) | 1.93% (301/15581) | 1.42% (22/1551) | 4,5 |
| Other origin | 5.71% (4/70) | 6.33% (361/5704) | 2.43% (379/15581) | 1.42% (22/1551) | 3,4,5,6 |
| PRHDs | 0.00% (0/71) | 2.22% (127/5714) | 2.51% (391/15591) | 5.41% (84/1552) | 3,5,6 |
| GDM | 0.00% (0/71) | 2.54% (145/5714) | 4.28% (667/15591) | 6.44% (100/1552) | 3,4,5,6 |
Acronyms: IUI Intrauterine insemination, IVF In vitro fertilization, ICSI Intracytoplasmatic sperm injection, PRHD Pregnancy related hypertensive disorder, GDM Gestational diabetes mellitus. Different numbers indicate statistically significant differences (p < 0.05): (1) < 17 years vs 18–28 years; (2) < 17 years vs 29–39 years; (3) < 17 years vs > 40 years; (4) 18–28 years vs 29–39 years; (5) 18–28 years vs > 40 years; (6) 29–39 years vs > 40 years. NS= no significant difference
Labor, delivery, and neonatal characteristics and neonatal outcomes
| < 17 years (71) | 18–28 years (5714) | 29–39 years (15591) | > 40 years (1552) |
| |
|---|---|---|---|---|---|
| Labor and delivery | |||||
| Abnormal fetal presentation | 4.23% (3/71) | 4.34% (248/5713) | 5.33% (831/15590) | 6.12% (95/1552) | 4,5 |
| Mode of labor | |||||
| Spontaneous | 71.21% (47/66) | 68.10% (3399/4991) | 63.22% (8478/13411) | 52.95% (726/1371) | 3,4,5,6 |
| Induced/augmented | 19.70% (13/66) | 22.30% (1113/4991) | 21.19% (2842/13411) | 19.69% (270/1371) | 5 |
| Without labor | 9.09% (6/66) | 9.60% (479/4991) | 15.59% (2091/13411) | 27.35% (375/1371) | 3,4,5,6 |
| Childbirth mode | |||||
| Operative vaginal delivery | 5.63% (4/71) | 8.58% (490/5714) | 7.25% (1130/15591) | 5.73% (89/1552) | 4,5,6 |
| Spontaneous delivery | 77.46% (55/71) | 67.12% (3835/5714) | 60.77% (9474/15591) | 48.84% (758/1552) | 2,3,4,5,6 |
| Caesarean section | 16.90% (12/71) | 24.31% (1389/5714) | 31.99% (4987/15591) | 45.43% (705/1552) | 2,3,4,5,6 |
| Caesarean section in labour | 8.33% (5/60) | 14.30% (645/4512) | 16.72% (1893/11320) | 22.09% (220/996) | 3,4,5,6 |
| Neonatal charateristics and outcomes | |||||
| RDS prophylaxis | |||||
| Not performed | 97.18% (69/71) | 96.04% (5488/5714) | 96.34% (15020/15591) | 94.33% (1464/1552) | 5,6 |
| Uncompleted | 2.82% (2/71) | 0.88% (50/5714) | 0.66% (103/15591) | 0.84% (13/1552) | 2 |
| Completed | 0.00% (0/71) | 3.08% (176/5714) | 3.00% (468/15591) | 4.83% (75/1552) | 5,6 |
| Neonatal male sex | 49.30% (35/71) | 51.40% (2937/5714) | 50.86% (7930/15591) | 51.29% (796/1552) | NS |
| 1st minute Apgar score | 8.00 (8.00–9.00) | 8.00 (8.00–9.00) | 8.00 (8.00–9.00) | 8.00 (8.00–9.00) | NS |
| 5th minute Apgar score | 9.00 (9.00–9.00) | 9.00 (9.00–9.00) | 9.00 (9.00–9.00) | 9.00 (9.00–9.00) | NS |
| Neonatal congenital malformation | 4.23% (3/71) | 1.38% (79/5714) | 1.50% (234/15591) | 2.06% (32/1552) | 1 |
| RDS | 7.04% (5/71) | 5.71% (326/5714) | 5.71% (890/15591) | 7.80% (121/1552) | 5,6 |
| Retinopathy of prematurity | 1.41% (1/71) | 0.82% (47/5714) | 0.90% (140/15591) | 1.10% (17/1552) | NS |
| 3rd 4th degree IVH | 1.41% (1/71) | 0.26% (15/5714) | 0.19% (29/15591) | 0.52% (8/1552) | 2,6 |
| Periventricular leucomalacia | 0.00% (0/71) | 0.16% (9/5714) | 0.08% (12/15591) | 0.32% (5/1552) | 6 |
| NR | 5.63% (4/71) | 3.45% (197/5714) | 3.30% (515/15588) | 4.38% (68/1552) | 6 |
| NICU hospitalization | 0.00% (0/71) | 0.02% (1/5711) | 0.03% (5/15582) | 0.00% (0/1551) | NS |
| Perinatal death | 0.00% (0/71) | 0.93% (53/5714) | 0.74% (116/15591) | 1.16% (18/1552) | NS |
| IUFD | 0.00% (0/71) | 0.30% (17/5714) | 0.37% (58/15591) | 0.45% (7/1552) | NS |
| Neonatal death | 0.00% (0/71) | 0.63% (36/5714) | 0.37% (58/15591) | 0.71% (11/1552) | 4,6 |
Acronyms: RDS Respiratory distress syndrome, IVH Intraventricular hemorrhage, NR Neonatal resuscitation, NICU Neonatal intensive care unit, IUFD Intrauterine fetal demise. Different numbers indicate statistically significant differences (p < 0.05): (1) < 17 years vs 18–28 years; (2) < 17 years vs 29–39 years; (3) < 17 years vs > 40 years; (4) 18–28 years vs 29–39 years; (5) 18–28 years vs > 40 years; (6) 29–39 years vs > 40 years. NS= no significant difference
Risk factors for the following specified pregnancy outcomes considered as dependent variables: delivery < 37 weeks’ gestation; pregnancy related hypertensive disorders; and caesarean section. Possible risk factors were considered as independent variables. Univariate and multivariate (*) logistic regression analysis were performed. (**) Excluded from the analysis non cephalic fetal presentation. (#) p-value corrected for the false discovery rate test
| OR (CI95%) |
| OR (CI95%) (*) | |||
|---|---|---|---|---|---|
| Delivery < 37 weeks’ gestation | |||||
| Maternal age > 40 years | 1.47 (1.27–1.71) | < 0.05 | 1.36 (1.16–1.61) | < 0.05 | < 0.05 |
| Nulliparous women | 1.26 (1.16–1.38) | < 0.05 | 1.31 (1.19–1.44) | < 0.05 | < 0.05 |
| Conception via assisted reproductive techniques | 1.53 (1.13–2.07) | < 0.05 | 1.24 (0.9–1.72) | 0.180 | 0.184 |
| PRHDs (ŧ) | 10.82 (9.16–12.78) | < 0.05 | 12.25 (10.02–14.99) | < 0.05 | < 0.05 |
| Low schooling (ŧ) | 1.25 (1.14–1.38) | < 0.05 | 1.31 (1.17–1.46) | < 0.05 | < 0.05 |
| Macro-region of origin | |||||
| Europe/Italy | Reference | Reference | |||
| Sub-Saharian Africa | 1.43 (1.19–1.73) | < 0.05 | 1.19 (0.97–1.47) | 0.090 | 0.106 |
| Arabian countries | 0.75 (0.56–1) | < 0.05 | 0.75 (0.55–1.01) | 0.060 | 0.077 |
| Other origin | 1.38 (1.11–1.71) | < 0.05 | 1.35 (1.08–1.69) | < 0.05 | < 0.05 |
| Pregnancy related hypertensive disorders | |||||
| Maternal age > 40 years | 2.32 (1.83–2.94) | < 0.05 | 2.36 (1.86–3.00) | < 0.05 | < 0.05 |
| Nulliparous women | 1.07 (0.91–1.26) | 0.439 | |||
| Conception via assisted reproductive techniques | 2.4 (1.53–3.75) | < 0.05 | 2.28 (1.45–3.58) | < 0.05 | < 0.05 |
| Low schooling | 1.53 (1.28–1.82) | < 0.05 | 1.4 (1.17–1.69) | < 0.05 | < 0.05 |
| Sub-Saharian Africa origin | 2.73 (2.08–3.58) | < 0.05 | 2.53 (1.91–3.36) | < 0.05 | < 0.05 |
| GDM | |||||
| Maternal age > 40 years | 1.74 (1.41–2.16) | < 0.05 | 1.71 (1.37–2.12) | < 0.05 | < 0.05 |
| Nulliparous women | 0.71 (0.62–0.82) | < 0.05 | 0.74 (0.64–0.84) | < 0.05 | < 0.05 |
| Conception via assisted reproductive techniques | 2.02 (1.35–3.03) | < 0.05 | 2.12 (1.4–3.19) | < 0.05 | < 0.05 |
| Low schooling | 1.08 (0.93–1.27) | 0.309 | |||
| Macro-region of origin | |||||
| Europe/Italy | Reference | Reference | |||
| Sub-Saharian Africa | 1.44 (1.08–1.91) | < 0.05 | 1.44 (1.08–1.93) | < 0.05 | < 0.05 |
| Arabian countries | 1.5 (1.07–2.11) | < 0.05 | 1.49 (1.05–2.1) | < 0.05 | < 0.05 |
| Other origin | 1.35 (0.97–1.87) | 0.077 | 1.33 (0.94–1.86) | 0.104 | 0.104 |
| Abnormal fetal presentation | |||||
| Maternal age > 40 years | 1.22 (0.98–1.52) | 0.068 | 1.29 (1.03–1.61) | < 0.05 | < 0.05 |
| Nulliparous women | 1.53 (1.35–1.73) | < 0.05 | 1.52 (1.34–1.73) | < 0.05 | < 0.05 |
| Conception via assisted reproductive techniques | 1.94 (1.34–2.8) | < 0.05 | 1.65 (1.14–2.39) | < 0.05 | < 0.05 |
| Arabian countries origin | 0.37 (0.21–0.64) | < 0.05 | 0.37 (0.21–0.66) | < 0.05 | < 0.05 |
| Caesarean section (**) | |||||
| Maternal age > 40 years | 2.03 (1.82–2.27) | < 0.05 | 1.99 (1.78–2.23) | < 0.05 | < 0.05 |
| Nulliparous women | 1.01 (0.95–1.07) | 0.774 | |||
| Conception via assisted reproductive techniques | 1.68 (1.34–2.12) | < 0.05 | 1.52 (1.20–1.93) | < 0.05 | < 0.05 |
| PRHDs (ŧŧ) | 4.74 (3.97–5.65) | < 0.05 | 29.6 (10.72–81.70) | < 0.05 | < 0.05 |
| Low schooling | 1.07 (1.00–1.15) | < 0.05 | 1.02 (0.95–1.10) | 0.610 | 0.612 |
| Sub-Saharian Africa origin | 1.61 (1.45–1.79) | < 0.05 | 1.63 (1.46–1.82) | < 0.05 | < 0.05 |
| Induced/augmented labor | 0.97 (0.89–1.05) | 0.400 | |||
| Neonatal weight (MoM) (ŧŧ) | 0.68 (0.55–0.85) | < 0.05 | 0.89 (0.71–1.12) | 0.330 | 0.379 |
Acronyms: PRHD Pregnancy related hypertensive disorder, MoM Multiple of median. Interaction terms: (ŧ) Interaction term for PRHDs and Low schooling OR 0.56 (CI95% 0.39–0.81) (p < 0.05); (ŧŧ) Interaction term for PRHDs and neonatal weight MoM OR 0.13 (CI95% 0.05–0.37)
Risk factors for the following specified neonatal outcomes considered as dependent variables: Fetal PVL and fetal IVH (3rd-4th degree). Possible risk factors were considered as independent variables. Univariate and multivariate (*) logistic regression analysis was performed. (#) p-value corrected for the false discovery rate test
| OR (CI95%) |
| OR (CI95%) (*) | |||
|---|---|---|---|---|---|
| Fetal PVL | |||||
| Maternal age > 40 years | 3.29 (1.24–8.73) | < 0.05 | 3.32 (1.17–9.44) | < 0.05 | 0.056 |
| Nulliparous women | 0.92 (0.43–1.99) | 0.835 | |||
| Conception via assisted reproductive techniques | 2.65 (0.36–19.65) | 0.339 | |||
| Low schooling | 2.15 (0.98–4.75) | 0.057 | 1.22 (0.52–2.88) | 0.650 | 0.754 |
| Sub-Saharian Africa/Arabian/Other origin | 3.8 (1.65–8.75) | < 0.05 | 2.71 (1.07–6.82) | < 0.05 | 0.061 |
| PRHDs | 6.54 (2.25–19.03) | < 0.05 | 1.06 (0.35–3.26) | 0.920 | 0.918 |
| Gestational age at birth (weeks) (ŧ) | 0.68 (0.63–0.72) | < 0.05 | 0.66 (0.6–0.73) | < 0.05 | < 0.05 |
| Prenatal RDS prophylaxis (ŧ) | 7.42 (4.95–11.13) | < 0.05 | 0.06 (0.00–1.00) | 0.050 | 0.070 |
| Fetal IVH (3rd-4th degree) | |||||
| Maternal age < 17 years or > 40 years | 2.69 (1.31–5.53) | < 0.05 | 2.97 (1.24–7.14) | < 0.05 | < 0.05 |
| Nulliparous women | 1.49 (0.84–2.64) | 0.17 | |||
| Conception via assisted reproductive techniques | 2.61 (0.63–10.75) | 0.185 | |||
| Low schooling | 1.49 (0.83–2.68) | 0.184 | |||
| Sub-Saharian Africa origin | 2.86 (1.22–6.71) | < 0.05 | 1.59 (0.59–4.28) | 0.360 | 0.481 |
| PRHDs | 2.99 (1.08–8.33) | < 0.05 | 0.71 (0.24–2.1) | 0.530 | 0.533 |
| Gestational age at birth (weeks) | 0.62 (0.58–0.66) | < 0.05 | 0.62 (0.58–0.66) | < 0.05 | < 0.05 |
Acronyms: PRHD Pregnancy related hypertensive disorder, PVL Periventricular leucomalacia, RDS Respiratory distress syndrome, IVH Intraventricular hemorrhage. Interaction terms: (ŧ) Interaction term for gestational age at birth and prenatal RDS prophylaxis OR 1.12 (CI95% 1.02–1.23) (p < 0.05)